E2F1 and colorectal carcinoma: Further, it’s figured out that NCAPD3 switched the glucose metabolism and enhanced the glucose glycolysis via up-regulating the activities of c-Myc and E2F1 pathways, which finally resulted in the colon tumorigenesis and CRC progression (Supplementary Fig. S6).